Laddar...
Biology and clinical application of CAR T Cells for B cell malignancies
Chimeric antigen receptor (CAR)-modified T cells have generated broad interest in oncology following a series of dramatic clinical successes in patients with chemorefractory B cell malignancies. CAR therapy now appears to be on the cusp of regulatory approval as a cell-based immunotherapy. We review...
Sparad:
| I publikationen: | Int J Hematol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5512169/ https://ncbi.nlm.nih.gov/pubmed/27262700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-016-2039-6 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|